Association of Total Mortality and Cardiovascular Endpoints With the Timing of the First and Second Systolic Peak of the Aortic Pulse Wave
Jazyk angličtina Země Spojené státy americké Médium print
Typ dokumentu časopisecké články
Grantová podpora
The Internal Medicine Service, Hospital Italiano de Buenos Aires, Buenos Aires
HEALTH-F7-305507 HOMAGE
Belgium (Leuven): European Union
2011-294713-EPLORE
European Research Council - International
713601-uPROPHET
European Research Council - International
JTC2017-046-PROACT
European Research Area Net for Cardiovascular Diseases
82070432
National Natural Science Foundation of China
82070435
National Natural Science Foundation of China
82270469
National Natural Science Foundation of China
81970353
National Natural Science Foundation of China
2022YFC3602400
National Key Research and Development Projects
2022YFC3602401
National Key Research and Development Projects
19ZR144330
Shanghai Commissions of Science and Technology
21TS1400300
Shanghai Commissions of Science and Technology
SHDC2020CR1042B
Shanghai Shenkang Hospital Development Center
20234Y0036
Shanghai Municipal Health Commission
202340035
Shanghai Municipal Health Commission
201940297
Shanghai Municipal Health Commission
GWV-10.1-XK05
Shanghai Municipal Health Commission
2022LJ022
Shanghai Municipal Health Commission
LSHM-CT-2006-037093
Czech Republic: European Union
HEALTH-F4-2007-201550
Czech Republic: European Union
Charles University Research Fund
Finnish Research Council
Finnish Foundation for Cardiovascular Research
LSHM-CT-2006037093
Italy: European Union
HEALTH-F4-2007201550
Italy: European Union
LSHM-CT-2006037093
Poland (Gdańsk): European Union
HEALTH-F4-2007201550
Poland (Gdańsk): European Union
LSHM-CT-2006037093
Poland (Kraków): European Union
HEALTH-F4-2007201550
Poland (Kraków): European Union
Foundation for Polish Science
PubMed
39821625
PubMed Central
PMC11771774
DOI
10.1111/jch.14962
Knihovny.cz E-zdroje
- Klíčová slova
- cardiovascular risk, mortality, population science, pulse wave transit time, waveform analysis,
- MeSH
- analýza pulzové vlny * metody MeSH
- aorta * patofyziologie MeSH
- časové faktory MeSH
- hodnocení rizik metody MeSH
- incidence MeSH
- kardiovaskulární nemoci * mortalita patofyziologie epidemiologie diagnóza MeSH
- lidé středního věku MeSH
- lidé MeSH
- prognóza MeSH
- rizikové faktory MeSH
- senioři MeSH
- srdeční frekvence fyziologie MeSH
- systola fyziologie MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
Prognostic significance of the timing in the cardiac cycle of the first (TP1) and second (TP2) systolic peak of the central aortic pulse wave is ill-defined. Incidence rates and standardized multivariable-adjusted hazard ratios (HRs) of adverse health outcomes associated with TP1 and TP2, estimated by the SphygmoCor software, were assessed in the International Database of Central Arterial Properties for Risk Stratification (IDCARS) (n = 5529). Model refinement was assessed by the integrated discrimination (ID) and net reclassification (NR) improvement. Over 4.1 years (median), 201 participants died and 248 and 159 patients experienced cardiovascular or cardiac endpoints. Mean TP1 and TP2, standardized for cohort, sex, age, and heart rate, were 103 and 228 ms. Shorter TP1 and TP2 were associated with higher mortality and shorter TP1 with a higher risk of cardiovascular and cardiac endpoints (trend p ≤ 0.004). The HRs relating total mortality and cardiovascular endpoints to TP2 were 0.82 (95% confidence interval [CI]: 0.72-0.94) and 0.87 (0.77-0.98), respectively. The HR relating cardiac endpoints to TP1 was 0.81 (0.68-0.97). For total mortality and cardiovascular endpoints in relation to TP2, NRI was significant (p ≤ 0.010), but not for cardiac endpoints in relation to TP1. Integrated discrimination improvement (IDI) was not significant for any endpoint. The HRs relating total mortality to TP2 were smaller (p ≤ 0.026) in women than men (0.67 vs. 0.95) and in older (≥ 60 years) versus younger (< 60 years) participants (0.80 vs. 0.88). Our study adds to the evidence supporting risk stratification based on aortic pulse analysis by showing that TP2 and TP1 carry prognostic information.
Biomedical Sciences Group Faculty of Medicine University of Leuven Leuven Belgium
Department of Cardiology Shanghai General Hospital Shanghai China
Department of Chronic Disease Prevention Finnish Institute for Health and Welfare Turku Finland
Department of Medicine Turku University Hospital and University of Turku Turku Finland
Department of Medicine University of Padua Padua Italy
Faculty of Medicine Charles University Pilsen Czech Republic
Non Profit Research Association Alliance for the Promotion of Preventive Medicine Leuven Belgium
Research Institute Alliance for the Promotion of Preventive Medicine Mechelen Belgium
Zobrazit více v PubMed
Avolio A. P., Van Bortel L. M., Boutouyrie P., et al., “Role of Pulse Pressure Amplification in Arterial Hypertension: Experts' Opinion and Review of the Data,” Hypertension 54 (2009): 375–383. PubMed
Pauca A. L., O'Rourke M., and Kon N. D., “Prospective Evaluation of a Method for Estimating Ascending Aortic Pressure From the Radial Artery Pressure Waveform,” Hypertension 38 (2001): 932–937. PubMed
Wang K. L., Cheng H. M., Chuang S. Y., et al., “Wave Reflection and Arterial Stiffness in the Prediction of 15‐Year All‐Cause and Cardiovascular Mortalities. A Community‐Based Study,” Hypertension 55 (2010): 799–805. PubMed PMC
Zamani P., Jacobs D. R. Jr., Segers P., Duprez D. A., et al., “Reflection Magnitude as a Predictor of Mortality: The Multi‐Ethnic Study of Atherosclerosis,” Hypertension 64 (2014): 958–964. PubMed PMC
Cooper L. L., Rong J., Benjamin E. J., et al., “Components of Hemodynamic Load and Cardiovascular Events,” Circulation 131 (2015): 354–361. PubMed PMC
Desbiens L. C., Fortier C., Nadeau‐Fredette A. C., et al., “Prediction of Cardiovascular Events by Pulse Waveform Parameters: Analysis of CARTaGENE,” Journal of the American Heart Association 11 (2022): e026603. PubMed PMC
Hayashi T., Nakayama Y., Tsumura K., Yoshimaru K., and Ueda H., “Reflection in the Arterial System and the Risk of Coronary Heart Disease,” American Journal of Hypertension 15 (2002): 405–409. PubMed
Ueda H., Hayashi T., Tsumura K., Yoshimaru K., Nakayama Y., and Yoshikawa J., “The Timing of the Reflected Wave in the Ascending Aortic Pressure Predicts Restenosis After Coronary Stent Placement,” Hypertension Research 27 (2004): 535–540. PubMed
Weber T., Auer J., O'Rourke M. F., et al., “Increased Arterial Wave Reflections Predict Severe Cardiovascular Events in Patients Undergoing Percutaneous Coronary Interventions,” European Heart Journal 26 (2005): 2657–2663. PubMed
Weber T., O'Rourke M. F., Lassnig E., et al., “Pulse Wave Characteristics Predict Cardiovascular Events and Mortality in Patients Undergoing Coronary Angiography,” Journal of Hypertension 28 (2010): 797–805. PubMed
Ueda H., Hayashi T., Tsumura K., Yoshimaru K., Nakayama Y., and Yoshikawa J., “Inflection Point of Ascending Aortic Waveform Is a Predictive Factor for All‐Cause and Cardiovascular Mortality in Patients With Chronic Renal Failure on Hemodialysis,” American Journal of Hypertension 17 (2004): 1151–1155. PubMed
Fortier C., Côté J., Mac‐Way F., et al., “Prognostic Value of Carotid and Radial Artery Reservoir‐Wave Parameters in End‐Stage Renal Disease,” Journal of the American Heart Association 8 (2019): e012314. PubMed PMC
Aparicio L. S., Huang Q. F., Melgarejo J. D., et al., “The International Database of Central Arterial Properties for Risk Stratification: Research Objectives and Baseline Characteristics of Participants,” American Journal of Hypertension 35 (2021): 54–64. PubMed PMC
World Medical Association , “World Medical Association Declaration of Helsinki. Ethical Principles for Medical Research Involving Human Subjects,” Journal of the American Medical Association 310 (2013): 2191–2194. PubMed
World Health Organization , Global Status Report on Alcohol and Health 2018. Geneva, Switzerland, World Health Organization, 2018.
Fay M. P. and Feuer E. J., “Confidence Intervals for Directly Standardized Rates: A Method Based on the Gamma Distribution,” Statistics in Medicine 16 (1997): 791–801. PubMed
Wojciechowska W., Staessen J. A., Nawrot T., et al., “Reference Values in White Europeans for the Arterial Pulse Wave Recorded by Means of the ShygmoCor Device,” Hypertension Research 29 (2006): 475–483. PubMed
Torjesen A. A., Wang N., Larson M. G., et al., “Forward and Backward Wave Morphology and Central Pressure Augmentation in Men and Women in the Framingham Heart Study,” Hypertension 64 (2014): 259–265. PubMed PMC
Chirinos J. A., Segers P., Hughes T., and Townsend R., “Large‐Artery Stiffness in Health and Disease: JACC State‐of‐the‐Art Review,” Journal of the American College of Cardiology 74 (2019): 1237–1263. PubMed PMC
O'Rourke M. F. and Safar M. E., “Relationship Between Aortic Stiffening and Microvascular Disease in Brain and Kidney. Cause and Logic of Therapy,” Hypertension 46 (2005): 200–204. PubMed
O'Rourke M. F. and Kelly P. J., “Wave Reflections in the Systemic Circulation and Its Implications in Ventricular Function,” Journal of Hypertension 11 (1993): 327–337. PubMed
Avolio A. P., Deng F. A., Li W. Q., et al., “Effects of Aging on Arterial Distensibility in Populations With High and Low Prevalence of Hypertension: Comparison between Urban and Rural Communities in China,” Circulation 71 (1985): 202–210. PubMed
Wagenseil J. and Mecham R. P., “Elastin in Large Artery Stiffness and Hypertension,” Journal of Cardiovascular Translational Research 5 (2012): 264–273. PubMed PMC
Li X., Zhu L., Wang B., Yuan M., and Zhu R., “Drugs and Targets in Fibrosis,” Frontiers in Pharmacology 8 (2017): 855. PubMed PMC
He S., Park S., and Fujii Y., “State‐Level Hypertension Prevalence and Control among Adults in the U.S,” American Journal of Preventive Medicine 65 (2024): 46–54, 10.1016/j.amepre.2023.09.010. PubMed DOI PMC
Boggia J., Thijs L., Hansen T. W., et al., “Ambulatory Blood Pressure Monitoring in 9357 Subjects from 11 Populations Highlights Missed Opportunities for Cardiovascular Prevention in Women,” Hypertension 57 (2011): 397–405. PubMed PMC
Cheng Y. B., Thijs L., Aparicio L. S., et al., “International Database of Central Arterial Properties for Risk Stratification (IDCARS) Investigators. Risk Stratification by Cross‐Classification of Central and Brachial Systolic Blood Pressure,” Hypertension 79 (2022): 1101–1111. PubMed PMC
Regitz‐Zagrosek V. and Gebhard C., “Gender Medicine: Effects of Sex and Gender On Cardiovascular Disease Manifestations and Outcomes,” Nature Reviews Cardiology 20 (2023): 236–247. PubMed PMC
Laurent S., Chatellier G., Azizi M., et al., “SPARTE Study: Normalization of Arterial Stiffness and Cardiovascular Events in Patients With Hypertension at Medium to Very High Risk,” Hypertension 78 (2021): 983–995. PubMed PMC
Williams B., Mancia G., Spiering W., et al., “2018 ESC/ESH Guidelines for the Management of Arterial Hypertension,” European Heart Journal 39 (2018): 3021–3104. PubMed
Upadhya B., Pajewski N. M., Rocco M. V., et al., “Effect of Intensive Blood Pressure Control on Aortic Stiffness in the SPRINT‐HEART,” Hypertension 77 (2021): 1571–1580. PubMed PMC
Segers P., Mahieu D., Kips J., and Van Bortel L. M., “The Use of a Generalized Transfer Function: Different Processing, Different Results!,” Journal of Hypertension 25 (2007): 1783–1787. PubMed
Chen C. H., Nevo E., Fetics B., et al., “Estimation of central Aortic Pressure Waveform by Mathematical Transformation of Radial Tonometry Pressure. Validation of Generalized Transfer Function,” Circulation 95 (1997): 1827–1836. PubMed
Sharman J. E., Lim R., Qasem A. M., et al., “Validation of a Generalized Transfer Function to Noninvasively Derived Central Blood Pressure During Exercise,” Hypertension 47 (2006): 1203–1208. PubMed
Riley R. D., Lambert P. C., and Abo‐Zaid G., “Meta‐Analysis of Individual Participant Data: Rationale, Conduct, and Reporting,” British Medical Journal 340 (2010): c221. PubMed
Odili A. N., Chori B. S., Danladi B., et al., “Electrocardiographic Left Ventricular Hypertrophy in Relation to Peripheral and Central Blood Pressure Indices in a Nigerian Population,” Blood Pressure 29 (2019): 39–46. PubMed
GBD 2019 Risk Factors Collaborators , “Global Burden of 87 Risk Factors in 204 Countries and territories, 1990‐2019: A Systematic Analysis for the Global Burden of Disease Study 2019,” Lancet 396 (2020): 1223–1249. PubMed PMC